Magazine Article | October 1, 2021

Why It's Never Too Early To Develop Your Exit Strategy

Source: Life Science Leader

By David Radlo

Sitting in the board meeting of our biotech company after turning cash-positive and operating for about a decade, we found ourselves deadlocked. With a 10-member board, five wanted as much money as quickly as possible, and the other five were satisfied with a better-than-market dividend while the company continued with double-digit growth.

We eventually agreed to have a sale committee and market the company through an investment banker to the highest possible bidder. We ended up selling to a reputable strategic partner. We ended up there because our focus was not on selling the company, but on growing the company. That is why I am a big believer in planning on potential exits early on.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: